Cargando…
Aeromonas punctata derived depolymerase improves susceptibility of Klebsiella pneumoniae biofilm to gentamicin
BACKGROUND: To overcome antibiotic resistance in biofilms, enzymes aimed at biofilm dispersal are under investigation. In the present study, applicability of an Aeromonas punctata derived depolymerase capable of degrading the capsular polysaccharide (CPS) of Klebsiella pneumoniae, in disrupting its...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4461996/ https://www.ncbi.nlm.nih.gov/pubmed/26063052 http://dx.doi.org/10.1186/s12866-015-0455-z |
_version_ | 1782375590565773312 |
---|---|
author | Bansal, Shruti Harjai, Kusum Chhibber, Sanjay |
author_facet | Bansal, Shruti Harjai, Kusum Chhibber, Sanjay |
author_sort | Bansal, Shruti |
collection | PubMed |
description | BACKGROUND: To overcome antibiotic resistance in biofilms, enzymes aimed at biofilm dispersal are under investigation. In the present study, applicability of an Aeromonas punctata derived depolymerase capable of degrading the capsular polysaccharide (CPS) of Klebsiella pneumoniae, in disrupting its biofilm and increasing gentamicin efficacy against biofilm was investigated. RESULTS: Intact biofilm of K. pneumoniae was recalcitrant to gentamicin due to lack of antibiotic penetration. On the other hand, gentamicin could not act on disrupted biofilm cells due to their presence in clusters. However, when depolymerase (20 units/ml) was used in combination with gentamicin (10 μg/ml), dispersal of CPS matrix by enzyme facilitated gentamicin penetration across biofilm. This resulted in significant reduction (p < 0.05) in bacterial count in intact and disrupted biofilms. Reduction in CPS after treatment with depolymerase was confirmed by confocal microscopy and enzyme linked lectinosorbent assay. Furthermore, to substantiate our study, the efficacy of bacterial depolymerase was compared with a phage borne depolymerase possessing similar application against K. pneumoniae. Although both were used at same concentration i.e. 20 units/ml, but a higher efficacy of bacterial depolymerase particularly against older biofilms was visibly clear over its phage counterpart. This could be explained due to high substrate affinity (indicated by K(m) value) and high turnover number (indicated by K(cat) value) of the bacterial depolymerase (K(m) = 89.88 μM, K(cat) = 285 s(−1)) over the phage derived one (K(m) = 150 μM, K(cat) = 107 s(−1)). CONCLUSION: Overall the study indicated that, the A. punctata derived depolymerase possesses antibiofilm potential and improves gentamicin efficacy against K. pneumoniae. Moreover, it can serve as a potential substitute to phage borne depolymerases for treating biofilms formed by K. pneumoniae. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12866-015-0455-z) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4461996 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-44619962015-06-11 Aeromonas punctata derived depolymerase improves susceptibility of Klebsiella pneumoniae biofilm to gentamicin Bansal, Shruti Harjai, Kusum Chhibber, Sanjay BMC Microbiol Methodology Article BACKGROUND: To overcome antibiotic resistance in biofilms, enzymes aimed at biofilm dispersal are under investigation. In the present study, applicability of an Aeromonas punctata derived depolymerase capable of degrading the capsular polysaccharide (CPS) of Klebsiella pneumoniae, in disrupting its biofilm and increasing gentamicin efficacy against biofilm was investigated. RESULTS: Intact biofilm of K. pneumoniae was recalcitrant to gentamicin due to lack of antibiotic penetration. On the other hand, gentamicin could not act on disrupted biofilm cells due to their presence in clusters. However, when depolymerase (20 units/ml) was used in combination with gentamicin (10 μg/ml), dispersal of CPS matrix by enzyme facilitated gentamicin penetration across biofilm. This resulted in significant reduction (p < 0.05) in bacterial count in intact and disrupted biofilms. Reduction in CPS after treatment with depolymerase was confirmed by confocal microscopy and enzyme linked lectinosorbent assay. Furthermore, to substantiate our study, the efficacy of bacterial depolymerase was compared with a phage borne depolymerase possessing similar application against K. pneumoniae. Although both were used at same concentration i.e. 20 units/ml, but a higher efficacy of bacterial depolymerase particularly against older biofilms was visibly clear over its phage counterpart. This could be explained due to high substrate affinity (indicated by K(m) value) and high turnover number (indicated by K(cat) value) of the bacterial depolymerase (K(m) = 89.88 μM, K(cat) = 285 s(−1)) over the phage derived one (K(m) = 150 μM, K(cat) = 107 s(−1)). CONCLUSION: Overall the study indicated that, the A. punctata derived depolymerase possesses antibiofilm potential and improves gentamicin efficacy against K. pneumoniae. Moreover, it can serve as a potential substitute to phage borne depolymerases for treating biofilms formed by K. pneumoniae. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12866-015-0455-z) contains supplementary material, which is available to authorized users. BioMed Central 2015-06-11 /pmc/articles/PMC4461996/ /pubmed/26063052 http://dx.doi.org/10.1186/s12866-015-0455-z Text en © Bansal et al. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Methodology Article Bansal, Shruti Harjai, Kusum Chhibber, Sanjay Aeromonas punctata derived depolymerase improves susceptibility of Klebsiella pneumoniae biofilm to gentamicin |
title | Aeromonas punctata derived depolymerase improves susceptibility of Klebsiella pneumoniae biofilm to gentamicin |
title_full | Aeromonas punctata derived depolymerase improves susceptibility of Klebsiella pneumoniae biofilm to gentamicin |
title_fullStr | Aeromonas punctata derived depolymerase improves susceptibility of Klebsiella pneumoniae biofilm to gentamicin |
title_full_unstemmed | Aeromonas punctata derived depolymerase improves susceptibility of Klebsiella pneumoniae biofilm to gentamicin |
title_short | Aeromonas punctata derived depolymerase improves susceptibility of Klebsiella pneumoniae biofilm to gentamicin |
title_sort | aeromonas punctata derived depolymerase improves susceptibility of klebsiella pneumoniae biofilm to gentamicin |
topic | Methodology Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4461996/ https://www.ncbi.nlm.nih.gov/pubmed/26063052 http://dx.doi.org/10.1186/s12866-015-0455-z |
work_keys_str_mv | AT bansalshruti aeromonaspunctataderiveddepolymeraseimprovessusceptibilityofklebsiellapneumoniaebiofilmtogentamicin AT harjaikusum aeromonaspunctataderiveddepolymeraseimprovessusceptibilityofklebsiellapneumoniaebiofilmtogentamicin AT chhibbersanjay aeromonaspunctataderiveddepolymeraseimprovessusceptibilityofklebsiellapneumoniaebiofilmtogentamicin |